DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

5.98 -0.27 (-4.32%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PGNX $5.98 -4.32%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.21
Previous Close $6.25
Daily Range $5.97 - $6.38
52-Week Range $3.10 - $7.84
Market Cap $415.9M
P/E Ratio 56.82
Dividend (Yield) $0.00 (0.0%)
Volume 767,059
Average Daily Volume 1,011,186
Current FY EPS $0.02

Sector

Healthcare

Industry

Drugs

Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website: http://www.progenics.com/

News & Commentary

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

Actavis' Q4 Earnings to Beat Expectations, Growth Continues - Analyst Blog

Actavis' Appeal Case for Namenda Gets Accelerated Hearing - Analyst Blog

Actavis' Appeal Case for Namenda Gets Accelerated Hearing - Analyst Blog

KaloBios Pharmaceuticals' KB001-A Fails Primary Endpoint - Analyst Blog

The Biggest Risks For Stocks In 2015?

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Tiger Management's Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, ...

Progenics Pharmaceutical (PGNX) Upgraded From Sell to Hold

Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street

Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street

Progenics Pharmaceuticals' (PGNX) CEO Mark Baker Q3 2014 Results - Earnings Call Transcript

See More PGNX News...

PGNX's Top Competitors

PGNX $5.98 (-4.32%)
Current stock: PGNX
GILD $104.83 (0.62%)
Current stock: GILD
AMGN $152.26 (-2.63%)
Current stock: AMGN
BIIB $389.16 (10.17%)
Current stock: BIIB